This invention relates to compounds of the Formula (I): ##STR00001## or a pharmaceutically acceptable salt, solvate, ester or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF- or combinations thereof.

 
Web www.patentalert.com

< Methods of using(+)-2-[1-(3-ethoxy-4methoxyphenyl)-2-methylsulfonylethyl]-- 4-acetylaminoisoindoline-1,3,-dione

> Tumour necrosis factor binding ligands

> Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
~ 00593